MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,309,000 | -62.3% | 342,550 | -19.4% | 0.71% | -56.4% |
| Q4 2017 | $3,468,000 | +136.2% | 425,000 | +70.0% | 1.62% | +138.2% |
| Q3 2017 | $1,468,000 | -61.3% | 250,000 | -64.5% | 0.68% | -80.2% |
| Q1 2016 | $3,791,000 | -29.6% | 704,572 | 0.0% | 3.43% | -4.8% |
| Q4 2015 | $5,383,000 | -8.4% | 704,572 | 0.0% | 3.60% | -29.3% |
| Q3 2015 | $5,876,000 | -22.5% | 704,572 | +7.8% | 5.10% | +1.4% |
| Q2 2015 | $7,581,000 | +60.9% | 653,494 | +24.7% | 5.02% | +57.0% |
| Q1 2015 | $4,713,000 | +6.3% | 524,252 | +25.0% | 3.20% | +48.4% |
| Q4 2014 | $4,433,000 | – | 419,388 | – | 2.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $2,440,000 | 0.40% |
| ArrowMark Colorado Holdings LLC | 942,059 | $1,715,000 | 0.03% |
| A.R.T. Advisors, LLC | 39,100 | $71,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 52,432 | $95,000 | 0.02% |
| Orbimed Advisors | 567,600 | $1,033,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 15,697 | $29,000 | 0.01% |
| Palo Alto Investors LP | 63,517 | $116,000 | 0.01% |
| Virtu KCG Holdings LLC | 90,063 | $164,000 | 0.00% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $18,000 | 0.00% |
| FRANKLIN RESOURCES INC | 2,182,185 | $3,972,000 | 0.00% |